Clinical Endocrinology: Research Advances

More recent research has led to increased understanding of the mechanisms underlying the body’s loss of sensitivity to insulin (commonly called insulin resistance) in type 2 diabetes and the development of new treatments for these individuals. For example, there is evidence to suggest that exercise and weight reduction both decrease insulin resistance. In fact, numerous studies including a landmark study funded by the NIH (the Diabetes Prevention Program), have shown that these two interventions increase sensitivity to insulin and reduce the development of diabetes in people with pre-diabetes. The prevention of diabetes improves the quality and length of life, but while reducing healthcare costs substantially. In addition, researchers have discovered new medications that improve blood sugar control and reduce the incidence of diabetes and its complications.

  • Case management in multiple pituitary hormone deficiencies
  • Endocrine disorders in hemoglobinopathies
  • Overview of Cellular Transplantation in Diabetes Mellitus
  • Updated approach for the management of thyroid nodules
  • Congenital Hypothyroidism
  • Adrenal hyperplasia
  • Persistent Comorbidities in Cushing ’s syndrome after Endocrine Cure

Related Conference of Clinical Endocrinology: Research Advances

September 09-10, 2024

7th Annual Meeting on Diabetes and Endocrinology

Paris, France
September 09-10, 2024

4th European Endocrinology and Diabetes Congress

Paris, France
September 25-26, 2024

5th World Summit on Diabetes Expo

Rome, Italy
October 14-15, 2024

3rd International Summit on Hormonal Disorders

Madrid, Spain
November 22-23, 2024

20th World Congress on Endocrinology & Diabetes

Amsterdam, Netherlands

Clinical Endocrinology: Research Advances Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in